A 45-nucleotide insertion in the NS2 gene is responsible for the cytopathogenicity of a bovine viral diarrhoea virus strain.
Cytopathogenicity (cp) markers have recently been investigated in the genomes of field isolates of bovine viral diarrhoea virus (BVDV). Most of the isolates originated from mucosal disease (MD) cases observed after vaccination with a live attenuated vaccine, termed here BVDV-X. The NS2-3 genes of these isolates and of the vaccine proved to be identical, including a 45-nucleotide (nt) viral insertion at nt position 4355. The insertion originated from the NS4B/5A junction region of the BVDV genome. Interestingly, in BVDV strain CP7 a 27-nt insertion originating from the NS2 is located exactly at the same position. Complete genome analysis of BVDV-X did not reveal further potential cp markers. Furthermore, expression studies indicated that the insertion promotes NS2-3 cleavage. In order to examine the possible role of the 45-nt insertion in viral cytopathogenicity in details, a full-length infectious cDNA clone of BVDV-X was generated, and bovine turbinate (BT) cells were transfected with RNA transcribed from the clone. The recovered virus, termed BVDV-XR, showed slight retardation in growth in comparison with the original BVDV-X, and induced cytopathogenic effect (CPE). Since the natural non-cytopathogenic (ncp) counterpart of the vaccine virus was not available, an insertion-negative mutant cDNA clone was generated from BVDV-XR by PCR-directed mutagenesis. The recovered virus, termed BVDV-XR-INS-, showed the same growth characteristics as its cp counterpart BVDV-XR, but caused no CPE. These findings provide a direct proof that the 45-nt insertion at position 4355 has a basic role in the cytopathogenic character of this BVDV strain.
Bálint
Adám
A
Department of Virology, Central Veterinary Institute, Tábornok u. 2, H-1149, Budapest, Hungary.
Baule
Claudia
C
Pálfi
Vilmos
V
Dencsö
László
L
Hornyák
Akos
A
Belák
Sándor
S
D000818:Animals; D001912:Bovine Virus Diarrhea-Mucosal Disease; D002417:Cattle; D002418:Cattle Diseases / Q000821:virology; D002460:Cell Line; D003588:Cytopathogenic Effect, Viral; D018076:DNA, Complementary; D001908:Diarrhea Viruses, Bovine Viral / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity*; D016679:Genome, Viral; D016254:Mutagenesis, Insertional; D014158:Transcription, Genetic; D014162:Transfection; D017361:Viral Nonstructural Proteins / Q000235:genetics; D014765:Viral Vaccines
D018076:DNA, Complementary; D017361:Viral Nonstructural Proteins; D014765:Viral Vaccines